×
You are about to review presentations, reports, filings and/or other materials regarding Delcath Systems, Inc. (NASDAQ: DCTH) that contain time-sensitive ...
See a full list of events and presentations as well as helpful resources covering Delcaths investors and studies in patients with metastatic ocular ...
Delcath Investor Relations: investorrelations@delcath.com. Accountants: Marcum LLP. Transfer Agent: American Stock Transfer & Trust Company, LLC
Mar 26, 2024 · Investor Relations Contact: Ben Shamsian Lytham Partners 646-829-9701 shamsian@lythampartners.com. DELCATH SYSTEMS, INC. Consolidated Balance ...
Investor Presentation. (NASDAQ: DCTH). November 2012 · 2. DELCATH SYSTEMS, INC. Forward-looking Statements · 3. DELCATH SYSTEMS, INC. Our Mission · 4. DELCATH ...
Missing: relations | Show results with:relations
Mar 20, 2024 · Delcath issued and sold 876,627 shares of its common stock (the "Common Stock ... Investor Relations Contact: Ben Shamsian ... (Nasdaq: DCTH) (" ...
Investor Relations Contact: Ben Shamsian Lytham Partners 646-829-9701 shamsian@lythampartners.com. Cision View original content to download multimedia:https ...
13 hours ago · ... Investor Relations Contact: Westwicke Partners investorrelations@delcath.com. Cision View original content to download multimedia:https://www ...
People also ask
Find annual and quearterly earnings data for Delcath Systems, Inc. Common Stock (DCTH) including earnings per share, earnings forecasts at Nasdaq.com.
(Nasdaq: DCTH), an interventional oncology company focused on the treatment of ... Delcath Investor Relations. Email: investorrelations@delcath.com. Hayden IR.